One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
PTH control and cardiovascular outcomes: does the treatment approach matter?
Pieter Evenepoel, Hanne Skou Jørgensen
doi : 10.1093/ndt/gfad062
Nephrology Dialysis Transplantation, Volume 38, Issue 8, August 2023, Pages 1777–1779
Sacubitril/valsartan in peritoneal dialysis—lessons from a pharmacokinetic study
Parminder K Judge, William G Herrington, Richard Haynes
doi : 10.1093/ndt/gfad066
SARS-CoV-2 infection provoking autoimmunity
Naim Mahroum, Yehuda Shoenfeld
doi : 10.1093/ndt/gfad077
Measure and risk: cystatin C, creatinine and controversy in CKD
Kate I Stevens, Jennifer S Lees
doi : 10.1093/ndt/gfad113
The role of complement in glomerulonephritis—are novel therapies ready for prime time?
Chee Kay Cheung, John P Dormer, Jonathan Barratt
doi : 10.1093/ndt/gfac296
Management of heart failure in patients with kidney disease—updates from the 2021 ESC guidelines
Nicola C Edwards, Anna M Price, Richard P Steeds, Charles J Ferro, Jonathan N Townend Birmingham Cardio-Renal Group
doi : 10.1093/ndt/gfad011
Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG)
Marc Hilhorst, Frederike J Bemelman, Annette Bruchfeld, Gema M Fernandez-Juarez, Jürgen Floege, Eleni Frangou, Dimitrios Goumenos, Cees van Kooten, Andreas Kronbichler, Kate I Stevens, Kultigin Turkmen, W Joost Wiersinga, Hans-Joachim Anders on behalf of the Immunonephrology Working Group of the European Renal Association
doi : 10.1093/ndt/gfad044
The impact of acute kidney injury with or without recovery on long-term kidney outcome in patients undergoing living liver transplantation
Ping-Fang Chiu, Pei-Ru Lin, Chun-Chieh Tsai, Yao-Peng Hsieh
doi : 10.1093/ndt/gfad005
Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial
Angela Yee-Moon Wang, Wai Kei Lo, Stephen Chi-Wai Cheung, Tak-Ka Tang, Yat-Yin Yau, Brian Hung-Hin Lang
doi : 10.1093/ndt/gfad043
Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI study
Stephan Nopp, Oliver Königsbrügge, Sabine Schmaldienst, Renate Klauser-Braun, Matthias Lorenz, Ingrid Pabinger, Marcus Säemann, Cihan Ay
doi : 10.1093/ndt/gfac321
Nephrosclerosis in young patients with malignant hypertension
Côme Bureau, Matthieu Jamme, Juliet Schurder, Mickaël Bobot, Thomas Robert, Aymeric Couturier, Alexandre Karras, Jean-Michel Halimi, Xavier Bellenfant, Eric Rondeau, Laurent Mesnard
doi : 10.1093/ndt/gfac324
A single centre in-depth analysis of death with a functioning kidney graft and reasons for overall graft failure
Manuel Mayrdorfer, Lutz Liefeldt, Bilgin Osmanodja, Marcel G Naik, Danilo Schmidt, Wiebke Duettmann, Charlotte Hammett, Eva Schrezenmeier, Frank Friedersdorff, Kaiyin Wu, Fabian Halleck, Klemens Budde
doi : 10.1093/ndt/gfac327
Dietary lithium intake, graft failure and mortality in kidney transplant recipients
Adrian Post, Daan Kremer, Dion Groothof, Ulrike Seidel, Patricia Huebbe, Casper F M Franssen, Ido P Kema, Kai Lüersen, Gerald Rimbach, Stephan J L Bakker
doi : 10.1093/ndt/gfac340
Pharmacokinetics and pharmacodynamics of sacubitril/valsartan in peritoneal dialysis patients
Yi He, Ying Jin, Hen Xue, Runhan Liu, Mengyu Zhang, Ruoxi Liao, Maoli Chen, Xueli Zhou, Xueqin He, Min Qin, Kuo Li, Huiqun Zou, Ying Gan, Zhenlei Wang, Li Zheng, Hui Zhong, Ping Fu
doi : 10.1093/ndt/gfad038
Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents—post hoc analyses of the ASCEND-ND and ASCEND-D trials
Ajay K Singh, Finnian R McCausland, Brian L Claggett, Christoph Wanner, Andrzej Wiecek, Michael B Atkins, Kevin Carroll, Vlado Perkovic, John J V McMurray, Janet Wittes, Steven Snapinn, Allison Blackorby, Amy Meadowcroft, Tara Barker, Tara DiMino, Stephen Mallett, Alexander R Cobitz, Scott D Solomon
doi : 10.1093/ndt/gfac342
GFR estimated with creatinine rather than cystatin C is more reflective of the true risk of adverse outcomes with low GFR in kidney transplant recipients
Mira T Keddis, Matthew R Howard, Leyton Galapia, Erin F Barreto, Nan Zhang, Richard J Butterfield, Andrew D Rule
doi : 10.1093/ndt/gfad007
Apelin is altered in subjects with autosomal dominant polycystic kidney disease and preserved kidney function
Peter Janssens, Wilfried Cools, Nadia de Mota, Jean-Paul Decuypere, Vicente Torres, Karl Martin Wissing, Rudi Vennekens, Bert Bammens, Catherine Llorens-Cortes, Djalila Mekahli
doi : 10.1093/ndt/gfad056
Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure
Wonkyung J Cho, Destiny Harden, Daiana Moreno, James E Dinulos, Paul E Hanna, Qiyu Wang, Arthur Y Kim, Meghan E Sise
doi : 10.1093/ndt/gfad058
The evaluation of penicillin allergy in dialysis patients
Simo Sirkeoja, Meeri Honkanen, Reetta Huttunen, Satu Mäkelä, Jaana Syrjänen
doi : 10.1093/ndt/gfad072
Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics
Laure Peyro-Saint-Paul, Clémence Bechade, Alexandre Cesbron, Danièle Debruyne, Marie Brionne, Sylvie Brucato, Mélanie Hanoy, Audrey Dumont, Anais R Briant, Jean-Jacques Parienti, Thierry Lobbedez, Maxence Ficheux
doi : 10.1093/ndt/gfad087
Is hyponatremia a novel marker of inflammation in patients with COVID-19?
Juan Carlos Ayus, Kamyar Kalantar-Zadeh, Ekamol Tantisattamo, Connie M Rhee, Armando L Negri
doi : 10.1093/ndt/gfad111
Correction to: Patient views regarding cannabis use in chronic kidney disease and kidney failure: a survey study
doi : 10.1093/ndt/gfad012
Correction to: Transition of care of adolescent kidney transplant recipients—a call to action
doi : 10.1093/ndt/gfad025
